MAOB and Alzheimer disease: Interestingly, the Mao-b inhibitors, such as selegiline, have been shown to possess the beneficial effects on cognitive impairment in AD patients (Burke et al., 1993; Tolbert and Fuller, 1996; Filip and Kolibás, 1999).